PortfoliosLab logoPortfoliosLab logo
ENTA vs. ASST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ENTA vs. ASST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enanta Pharmaceuticals, Inc. (ENTA) and Strive, Inc. (ASST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both investments are quite close, with ENTA having a -16.55% return and ASST slightly higher at -16.40%.


ENTA

1D
-4.22%
1M
3.95%
6M
4.36%
YTD
-16.55%
1Y
74.54%
3Y*
-11.21%
5Y*
-20.55%
10Y*
-5.08%
ALL TIME*
-0.73%

ASST

1D
4.05%
1M
-16.90%
6M
-34.92%
YTD
-16.40%
1Y
-86.35%
3Y*
-53.15%
5Y*
10Y*
ALL TIME*
-67.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ENTA vs. ASST - Yearly Performance Comparison


2026 (YTD)202520242023
ENTA
Enanta Pharmaceuticals, Inc.
-16.55%174.26%-38.89%-82.16%
ASST
Strive, Inc.
-16.40%50.46%-84.65%-89.13%

Correlation

The correlation between ENTA and ASST is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Feb 3, 2023

0.07

Fundamentals

Market Cap

ENTA:

$305.53M

ASST:

$1.22B

EPS

ENTA:

-$2.60

ASST:

-$19.16

PS Ratio

ENTA:

4.54

ASST:

77.49

Total Revenue (TTM)

ENTA:

$69.21M

ASST:

$5.73M

Gross Profit (TTM)

ENTA:

$33.44M

ASST:

-$7.43M

EBITDA (TTM)

ENTA:

-$61.85M

ASST:

-$304.63M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ENTA vs. ASST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENTA
ENTA Risk / Return Rank: 7979
Overall Rank
ENTA Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
ENTA Sortino Ratio Rank: 8585
Sortino Ratio Rank
ENTA Omega Ratio Rank: 8484
Omega Ratio Rank
ENTA Calmar Ratio Rank: 8181
Calmar Ratio Rank
ENTA Martin Ratio Rank: 7676
Martin Ratio Rank

ASST
ASST Risk / Return Rank: 1616
Overall Rank
ASST Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
ASST Sortino Ratio Rank: 1414
Sortino Ratio Rank
ASST Omega Ratio Rank: 1717
Omega Ratio Rank
ASST Calmar Ratio Rank: 88
Calmar Ratio Rank
ASST Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENTA vs. ASST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enanta Pharmaceuticals, Inc. (ENTA) and Strive, Inc. (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ENTAASSTDifference
Sharpe ratioReturn per unit of total volatility

+1.27

Sortino ratioReturn per unit of downside risk

+3.25

Omega ratioGain probability vs. loss probability

1.29

0.90

+0.39

Calmar ratioReturn relative to maximum drawdown

2.18

-0.90

+3.09

Martin ratioReturn relative to average drawdown

3.95

-1.05

+5.00

ENTA vs. ASST - Sharpe Ratio Comparison

The current ENTA Sharpe Ratio is 0.69, which is higher than the ASST Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of ENTA and ASST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ENTA vs. ASST - Drawdown Comparison

The maximum ENTA drawdown since its inception was -96.63%, roughly equal to the maximum ASST drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for ENTA and ASST.


Loading charts...

Drawdown Indicators


ENTAASSTDifference

Max Drawdown

Largest peak-to-trough decline

-96.63%

-98.78%

+2.15%

Max Drawdown (1Y)

Largest decline over 1 year

-34.30%

-95.98%

+61.68%

Max Drawdown (3Y)

Largest decline over 3 years

-78.51%

-97.25%

+18.74%

Max Drawdown (5Y)

Largest decline over 5 years

-95.62%

Max Drawdown (10Y)

Largest decline over 10 years

-96.63%

Current Drawdown

Current decline from peak

-89.59%

-97.90%

+8.31%

Average Drawdown

Average peak-to-trough decline

-49.56%

-90.60%

+41.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.94%

82.22%

-63.28%

Volatility

ENTA vs. ASST - Volatility Comparison

The current volatility for Enanta Pharmaceuticals, Inc. (ENTA) is 14.22%, while Strive, Inc. (ASST) has a volatility of 25.01%. This indicates that ENTA experiences smaller price fluctuations and is considered to be less risky than ASST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ENTAASSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.22%

25.01%

-10.79%

Volatility (6M)

Calculated over the trailing 6-month period

34.52%

76.07%

-41.55%

Volatility (1Y)

Calculated over the trailing 1-year period

109.43%

147.69%

-38.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.65%

318.38%

-244.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.78%

318.38%

-257.60%

Dividends

ENTA vs. ASST - Dividend Comparison

Neither ENTA nor ASST has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ENTA vs. ASST - Financials Comparison

This section allows you to compare key financial metrics between Enanta Pharmaceuticals, Inc. and Strive, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
17.16M
2.76M
(ENTA) Total Revenue
(ASST) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ENTA and ASST have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASST has higher volatility (25.01%) compared to ENTA (14.22%). In terms of maximum drawdown, ENTA dropped -96.63% vs ASST's -98.78%.

ENTA currently has the higher Sharpe Ratio (0.69 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ENTA and ASST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer